Citation
Seow Heng Fong
(2011)
Epstein-barr virus specific immunogen.
PI2011700106.
Abstract
The present invention relates to an Epstein-Barr virus specific immunogen based on the LMP2 (latent membrane protein 2) gene. Furthermore, the present invention describes variants of the immunogen as well as polynucleotides coding for the peptide-immunogen and host cells transfected with the polynucleotides. The immunogens of the present invention are specifically useful to induce an CTL immune response in patient suffering from nsaopharyngeal carcinoma. Also embodied are novel methods for the in-vitro activation of CTLs using the aforementioned immunogens.
Download File
Full text not available from this repository.
|
Additional Metadata
| Item Type: | Patent |
|---|---|
| Application Number: | PI2011700106 |
| Filing Date: | 2011-07-11 |
| Divisions: | Faculty of Medicine and Health Science |
| Keywords: | Immunogen; Epstein-barr virus; Latent membrane protein 2 |
| Depositing User: | Suzila Mohamad Kasim |
| Date Deposited: | 24 Dec 2014 05:01 |
| Last Modified: | 24 Dec 2014 05:01 |
| URI: | http://psasir.upm.edu.my/id/eprint/33162 |
| Statistic Details: | View Download Statistic |
Actions (login required)
 |
View Item |